Zinc in PDB 5acx: Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
Enzymatic activity of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
All present enzymatic activity of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening:
3.5.2.6;
Protein crystallography data
The structure of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening, PDB code: 5acx
was solved by
T.Christopeit,
T.J.O.Carlsen,
R.Helland,
H.K.S.Leiros,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
39.61 /
1.80
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
101.230,
79.220,
67.640,
90.00,
130.18,
90.00
|
R / Rfree (%)
|
14.5 /
19.3
|
Other elements in 5acx:
The structure of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
(pdb code 5acx). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 6 binding sites of Zinc where determined in the
Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening, PDB code: 5acx:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
Zinc binding site 1 out
of 6 in 5acx
Go back to
Zinc Binding Sites List in 5acx
Zinc binding site 1 out
of 6 in the Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn1001
b:19.9
occ:1.00
|
ND1
|
A:HIS118
|
1.9
|
17.3
|
1.0
|
HO
|
A:OH1299
|
1.9
|
18.1
|
1.0
|
O
|
A:OH1299
|
2.0
|
15.1
|
1.0
|
NE2
|
A:HIS196
|
2.1
|
13.7
|
1.0
|
NE2
|
A:HIS116
|
2.2
|
12.8
|
1.0
|
CE1
|
A:HIS118
|
2.8
|
20.2
|
1.0
|
CG
|
A:HIS118
|
2.9
|
16.3
|
1.0
|
HB2
|
A:HIS118
|
2.9
|
17.2
|
1.0
|
HE1
|
A:HIS118
|
3.0
|
24.3
|
1.0
|
CE1
|
A:HIS116
|
3.0
|
13.2
|
1.0
|
CE1
|
A:HIS196
|
3.0
|
14.4
|
1.0
|
CD2
|
A:HIS196
|
3.1
|
13.3
|
1.0
|
HE1
|
A:HIS116
|
3.1
|
15.9
|
1.0
|
HE1
|
A:HIS196
|
3.2
|
17.3
|
1.0
|
HD2
|
A:HIS196
|
3.3
|
15.9
|
1.0
|
CD2
|
A:HIS116
|
3.3
|
12.8
|
1.0
|
CB
|
A:HIS118
|
3.3
|
14.3
|
1.0
|
HB3
|
A:HIS118
|
3.5
|
17.2
|
1.0
|
HD2
|
A:HIS116
|
3.5
|
15.4
|
1.0
|
OD3
|
A:OCS221
|
3.6
|
18.8
|
0.1
|
O18
|
A:WL31298
|
3.7
|
45.6
|
1.0
|
ZN
|
A:ZN1002
|
3.7
|
28.8
|
1.0
|
HB2
|
A:OCS221
|
3.9
|
19.8
|
1.0
|
NE2
|
A:HIS118
|
3.9
|
20.7
|
1.0
|
CD2
|
A:HIS118
|
4.0
|
19.1
|
1.0
|
OD1
|
A:ASP120
|
4.0
|
23.0
|
1.0
|
H03
|
A:WL31298
|
4.0
|
55.6
|
1.0
|
C03
|
A:WL31298
|
4.1
|
46.4
|
1.0
|
C17
|
A:WL31298
|
4.1
|
46.5
|
1.0
|
C16
|
A:WL31298
|
4.1
|
46.1
|
1.0
|
ND1
|
A:HIS196
|
4.1
|
13.3
|
1.0
|
HB3
|
A:OCS221
|
4.2
|
19.8
|
1.0
|
ND1
|
A:HIS116
|
4.2
|
12.2
|
1.0
|
O15
|
A:WL31298
|
4.2
|
46.6
|
1.0
|
CG
|
A:HIS196
|
4.2
|
12.4
|
1.0
|
HD21
|
A:ASN233
|
4.3
|
41.2
|
0.6
|
CG
|
A:HIS116
|
4.3
|
12.1
|
1.0
|
CB
|
A:OCS221
|
4.4
|
16.5
|
1.0
|
SG
|
A:OCS221
|
4.5
|
20.2
|
1.0
|
H
|
A:HIS118
|
4.6
|
17.6
|
1.0
|
OD2
|
A:ASP120
|
4.7
|
21.0
|
1.0
|
HE2
|
A:HIS118
|
4.7
|
24.8
|
1.0
|
C02
|
A:WL31298
|
4.7
|
46.9
|
1.0
|
C04
|
A:WL31298
|
4.8
|
47.3
|
1.0
|
CG
|
A:ASP120
|
4.8
|
26.1
|
1.0
|
CA
|
A:HIS118
|
4.8
|
15.2
|
1.0
|
HB3
|
A:SER197
|
4.8
|
16.7
|
1.0
|
C12
|
A:WL31298
|
4.8
|
47.1
|
1.0
|
HG2
|
A:ARG121
|
4.9
|
20.1
|
1.0
|
HD2
|
A:HIS118
|
4.9
|
22.9
|
1.0
|
HD1
|
A:HIS116
|
4.9
|
14.7
|
1.0
|
HD1
|
A:HIS196
|
4.9
|
16.0
|
1.0
|
ND2
|
A:ASN233
|
5.0
|
34.4
|
0.6
|
|
Zinc binding site 2 out
of 6 in 5acx
Go back to
Zinc Binding Sites List in 5acx
Zinc binding site 2 out
of 6 in the Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn1002
b:28.8
occ:1.00
|
OD3
|
A:OCS221
|
1.8
|
18.8
|
0.1
|
HO
|
A:OH1299
|
2.0
|
18.1
|
1.0
|
O15
|
A:WL31298
|
2.1
|
46.6
|
1.0
|
OD1
|
A:OCS221
|
2.2
|
24.4
|
0.1
|
SG
|
A:OCS221
|
2.3
|
20.2
|
1.0
|
NE2
|
A:HIS263
|
2.3
|
30.5
|
1.0
|
O
|
A:OH1299
|
2.4
|
15.1
|
1.0
|
OD2
|
A:ASP120
|
2.6
|
21.0
|
1.0
|
HB3
|
A:OCS221
|
2.9
|
19.8
|
1.0
|
HH21
|
A:ARG121
|
3.0
|
30.9
|
1.0
|
CB
|
A:OCS221
|
3.1
|
16.5
|
1.0
|
C12
|
A:WL31298
|
3.2
|
47.1
|
1.0
|
CE1
|
A:HIS263
|
3.2
|
29.4
|
1.0
|
CD2
|
A:HIS263
|
3.3
|
23.9
|
1.0
|
HE1
|
A:HIS263
|
3.4
|
35.2
|
1.0
|
HD2
|
A:HIS263
|
3.4
|
28.7
|
1.0
|
HE
|
A:ARG121
|
3.4
|
23.5
|
1.0
|
HE1
|
A:HIS116
|
3.6
|
15.9
|
1.0
|
CG
|
A:ASP120
|
3.6
|
26.1
|
1.0
|
HB2
|
A:OCS221
|
3.6
|
19.8
|
1.0
|
OD2
|
A:OCS221
|
3.6
|
19.2
|
0.0
|
C10
|
A:WL31298
|
3.6
|
46.9
|
1.0
|
ZN
|
A:ZN1001
|
3.7
|
19.9
|
1.0
|
NH2
|
A:ARG121
|
3.8
|
25.8
|
1.0
|
OD1
|
A:ASP120
|
3.9
|
23.0
|
1.0
|
C01
|
A:WL31298
|
4.0
|
46.3
|
1.0
|
C16
|
A:WL31298
|
4.0
|
46.1
|
1.0
|
NE
|
A:ARG121
|
4.2
|
19.6
|
1.0
|
H04
|
A:WL31298
|
4.2
|
56.8
|
1.0
|
O18
|
A:WL31298
|
4.2
|
45.6
|
1.0
|
O
|
A:HOH2243
|
4.3
|
21.7
|
1.0
|
NE2
|
A:HIS196
|
4.3
|
13.7
|
1.0
|
O14
|
A:WL31298
|
4.3
|
45.8
|
1.0
|
ND1
|
A:HIS263
|
4.3
|
21.5
|
1.0
|
CE1
|
A:HIS116
|
4.3
|
13.2
|
1.0
|
HA
|
A:OCS221
|
4.3
|
14.4
|
1.0
|
HH22
|
A:ARG121
|
4.4
|
30.9
|
1.0
|
CG
|
A:HIS263
|
4.4
|
18.1
|
1.0
|
C09
|
A:WL31298
|
4.4
|
46.6
|
1.0
|
CA
|
A:OCS221
|
4.4
|
12.0
|
1.0
|
HE1
|
A:HIS196
|
4.4
|
17.3
|
1.0
|
CZ
|
A:ARG121
|
4.5
|
23.7
|
1.0
|
CE1
|
A:HIS196
|
4.5
|
14.4
|
1.0
|
C17
|
A:WL31298
|
4.5
|
46.5
|
1.0
|
HA3
|
A:GLY262
|
4.6
|
16.4
|
1.0
|
H09
|
A:WL31298
|
4.6
|
55.9
|
1.0
|
C04
|
A:WL31298
|
4.6
|
47.3
|
1.0
|
NE2
|
A:HIS116
|
4.6
|
12.8
|
1.0
|
CB
|
A:ASP120
|
4.9
|
29.8
|
1.0
|
HG2
|
A:ARG121
|
4.9
|
20.1
|
1.0
|
HB2
|
A:ASP120
|
4.9
|
35.8
|
1.0
|
C11
|
A:WL31298
|
5.0
|
47.0
|
1.0
|
|
Zinc binding site 3 out
of 6 in 5acx
Go back to
Zinc Binding Sites List in 5acx
Zinc binding site 3 out
of 6 in the Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn1003
b:15.1
occ:0.95
|
NE2
|
A:HIS170
|
2.0
|
13.6
|
1.0
|
CL
|
A:CL1300
|
2.1
|
30.0
|
1.0
|
CL
|
A:CL1301
|
2.2
|
20.7
|
1.0
|
CE1
|
A:HIS170
|
2.8
|
15.5
|
1.0
|
HE1
|
A:HIS170
|
2.9
|
18.6
|
1.0
|
CD2
|
A:HIS170
|
3.1
|
12.4
|
1.0
|
HD2
|
A:HIS170
|
3.4
|
14.9
|
1.0
|
HB2
|
A:ALA135
|
3.6
|
14.1
|
1.0
|
HB3
|
A:ALA135
|
3.9
|
14.1
|
1.0
|
ND1
|
A:HIS170
|
4.0
|
16.7
|
1.0
|
CG
|
A:HIS170
|
4.1
|
13.6
|
1.0
|
HG22
|
A:THR169
|
4.2
|
18.4
|
1.0
|
CB
|
A:ALA135
|
4.2
|
11.7
|
1.0
|
O
|
A:HOH2163
|
4.5
|
31.0
|
1.0
|
HA
|
A:ALA135
|
4.6
|
14.9
|
1.0
|
HG23
|
A:THR169
|
4.7
|
18.4
|
1.0
|
HD1
|
A:HIS170
|
4.7
|
20.1
|
1.0
|
HH
|
A:TYR137
|
4.9
|
21.5
|
1.0
|
CG2
|
A:THR169
|
4.9
|
15.3
|
1.0
|
HB1
|
A:ALA135
|
5.0
|
14.1
|
1.0
|
|
Zinc binding site 4 out
of 6 in 5acx
Go back to
Zinc Binding Sites List in 5acx
Zinc binding site 4 out
of 6 in the Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn1001
b:21.3
occ:1.00
|
HO
|
B:OH1299
|
1.9
|
23.2
|
1.0
|
ND1
|
B:HIS118
|
1.9
|
18.6
|
1.0
|
O
|
B:OH1299
|
2.0
|
19.4
|
1.0
|
NE2
|
B:HIS196
|
2.0
|
14.1
|
1.0
|
NE2
|
B:HIS116
|
2.2
|
14.7
|
1.0
|
HB2
|
B:HIS118
|
2.9
|
22.1
|
1.0
|
CE1
|
B:HIS118
|
2.9
|
23.1
|
1.0
|
CG
|
B:HIS118
|
3.0
|
16.6
|
1.0
|
CE1
|
B:HIS196
|
3.0
|
14.2
|
1.0
|
CD2
|
B:HIS196
|
3.0
|
12.6
|
1.0
|
CE1
|
B:HIS116
|
3.1
|
15.7
|
1.0
|
HE1
|
B:HIS118
|
3.1
|
27.8
|
1.0
|
HE1
|
B:HIS116
|
3.2
|
18.8
|
1.0
|
HE1
|
B:HIS196
|
3.2
|
17.0
|
1.0
|
HD2
|
B:HIS196
|
3.2
|
15.2
|
1.0
|
CD2
|
B:HIS116
|
3.2
|
15.1
|
1.0
|
CB
|
B:HIS118
|
3.3
|
18.4
|
1.0
|
OD2
|
B:OCS221
|
3.4
|
19.9
|
0.1
|
HD2
|
B:HIS116
|
3.4
|
18.2
|
1.0
|
O18
|
B:WL31298
|
3.5
|
35.3
|
1.0
|
HB3
|
B:HIS118
|
3.5
|
22.1
|
1.0
|
ZN
|
B:ZN1002
|
3.7
|
28.6
|
1.0
|
HB2
|
B:OCS221
|
3.8
|
17.4
|
1.0
|
NE2
|
B:HIS118
|
4.0
|
20.8
|
1.0
|
O15
|
B:WL31298
|
4.1
|
36.5
|
1.0
|
CD2
|
B:HIS118
|
4.1
|
17.5
|
1.0
|
ND1
|
B:HIS196
|
4.1
|
13.4
|
1.0
|
C16
|
B:WL31298
|
4.1
|
36.5
|
1.0
|
CG
|
B:HIS196
|
4.1
|
13.0
|
1.0
|
HB3
|
B:OCS221
|
4.1
|
17.4
|
1.0
|
H03
|
B:WL31298
|
4.1
|
45.5
|
1.0
|
OD1
|
B:ASP120
|
4.2
|
24.3
|
1.0
|
ND1
|
B:HIS116
|
4.2
|
14.8
|
1.0
|
C03
|
B:WL31298
|
4.2
|
37.9
|
1.0
|
C17
|
B:WL31298
|
4.2
|
37.8
|
1.0
|
CB
|
B:OCS221
|
4.3
|
14.5
|
1.0
|
CG
|
B:HIS116
|
4.3
|
14.1
|
1.0
|
HD21
|
B:ASN233
|
4.4
|
63.9
|
1.0
|
SG
|
B:OCS221
|
4.4
|
18.7
|
1.0
|
H
|
B:HIS118
|
4.6
|
21.9
|
1.0
|
OD2
|
B:ASP120
|
4.6
|
23.1
|
1.0
|
CA
|
B:HIS118
|
4.8
|
19.6
|
1.0
|
HB3
|
B:SER197
|
4.8
|
13.1
|
1.0
|
HE2
|
B:HIS118
|
4.8
|
24.9
|
1.0
|
CG
|
B:ASP120
|
4.8
|
25.8
|
1.0
|
HG2
|
B:ARG121
|
4.9
|
19.2
|
1.0
|
C12
|
B:WL31298
|
4.9
|
38.8
|
1.0
|
HD1
|
B:HIS196
|
4.9
|
16.1
|
1.0
|
HD2
|
B:HIS118
|
4.9
|
21.1
|
1.0
|
HE
|
B:ARG121
|
4.9
|
22.6
|
1.0
|
HD1
|
B:HIS116
|
4.9
|
17.8
|
1.0
|
C04
|
B:WL31298
|
4.9
|
39.2
|
1.0
|
C02
|
B:WL31298
|
5.0
|
39.5
|
1.0
|
HG3
|
B:ARG121
|
5.0
|
19.2
|
1.0
|
|
Zinc binding site 5 out
of 6 in 5acx
Go back to
Zinc Binding Sites List in 5acx
Zinc binding site 5 out
of 6 in the Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn1002
b:28.6
occ:1.00
|
OD2
|
B:OCS221
|
1.7
|
19.9
|
0.1
|
O
|
B:OH1299
|
2.0
|
19.4
|
1.0
|
OD3
|
B:OCS221
|
2.1
|
16.5
|
0.4
|
O15
|
B:WL31298
|
2.2
|
36.5
|
1.0
|
SG
|
B:OCS221
|
2.2
|
18.7
|
1.0
|
NE2
|
B:HIS263
|
2.3
|
22.1
|
1.0
|
OD2
|
B:ASP120
|
2.5
|
23.1
|
1.0
|
HO
|
B:OH1299
|
2.9
|
23.2
|
1.0
|
HB3
|
B:OCS221
|
3.0
|
17.4
|
1.0
|
HH21
|
B:ARG121
|
3.0
|
25.6
|
1.0
|
CB
|
B:OCS221
|
3.2
|
14.5
|
1.0
|
CD2
|
B:HIS263
|
3.2
|
24.4
|
1.0
|
C12
|
B:WL31298
|
3.3
|
38.8
|
1.0
|
HD2
|
B:HIS263
|
3.3
|
29.3
|
1.0
|
CE1
|
B:HIS263
|
3.3
|
20.8
|
1.0
|
HE
|
B:ARG121
|
3.4
|
22.6
|
1.0
|
OD1
|
B:OCS221
|
3.5
|
22.7
|
0.2
|
HE1
|
B:HIS263
|
3.5
|
25.0
|
1.0
|
CG
|
B:ASP120
|
3.6
|
25.8
|
1.0
|
HB2
|
B:OCS221
|
3.6
|
17.4
|
1.0
|
HE1
|
B:HIS116
|
3.6
|
18.8
|
1.0
|
ZN
|
B:ZN1001
|
3.7
|
21.3
|
1.0
|
C10
|
B:WL31298
|
3.7
|
38.5
|
1.0
|
NH2
|
B:ARG121
|
3.8
|
21.3
|
1.0
|
C16
|
B:WL31298
|
3.9
|
36.5
|
1.0
|
C01
|
B:WL31298
|
4.0
|
37.0
|
1.0
|
OD1
|
B:ASP120
|
4.0
|
24.3
|
1.0
|
O18
|
B:WL31298
|
4.1
|
35.3
|
1.0
|
H04
|
B:WL31298
|
4.2
|
47.1
|
1.0
|
NE
|
B:ARG121
|
4.2
|
18.8
|
1.0
|
O
|
B:HOH2231
|
4.3
|
22.4
|
1.0
|
NE2
|
B:HIS196
|
4.3
|
14.1
|
1.0
|
HA
|
B:OCS221
|
4.3
|
15.4
|
1.0
|
O14
|
B:WL31298
|
4.4
|
35.4
|
1.0
|
CG
|
B:HIS263
|
4.4
|
20.6
|
1.0
|
HE1
|
B:HIS196
|
4.4
|
17.0
|
1.0
|
CE1
|
B:HIS116
|
4.4
|
15.7
|
1.0
|
ND1
|
B:HIS263
|
4.4
|
19.7
|
1.0
|
CA
|
B:OCS221
|
4.4
|
12.8
|
1.0
|
HH22
|
B:ARG121
|
4.4
|
25.6
|
1.0
|
CE1
|
B:HIS196
|
4.5
|
14.2
|
1.0
|
CZ
|
B:ARG121
|
4.5
|
20.9
|
1.0
|
HA3
|
B:GLY262
|
4.5
|
18.9
|
1.0
|
C17
|
B:WL31298
|
4.5
|
37.8
|
1.0
|
C09
|
B:WL31298
|
4.5
|
36.9
|
1.0
|
C04
|
B:WL31298
|
4.5
|
39.2
|
1.0
|
NE2
|
B:HIS116
|
4.6
|
14.7
|
1.0
|
H09
|
B:WL31298
|
4.8
|
44.3
|
1.0
|
CB
|
B:ASP120
|
4.9
|
27.6
|
1.0
|
HB2
|
B:ASP120
|
4.9
|
33.1
|
1.0
|
H
|
B:OCS221
|
5.0
|
15.5
|
1.0
|
HG2
|
B:ARG121
|
5.0
|
19.2
|
1.0
|
|
Zinc binding site 6 out
of 6 in 5acx
Go back to
Zinc Binding Sites List in 5acx
Zinc binding site 6 out
of 6 in the Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of Vim-2-2, Discovery of Novel Inhibitor Scaffolds Against the Metallo- Beta-Lactamase Vim-2 By Spr Based Fragment Screening within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn1003
b:20.1
occ:1.00
|
HE2
|
B:HIS170
|
1.8
|
29.8
|
1.0
|
HE1
|
B:HIS170
|
1.9
|
37.8
|
1.0
|
NE2
|
B:HIS170
|
2.2
|
24.8
|
1.0
|
CL
|
B:CL1301
|
2.2
|
25.8
|
1.0
|
CE1
|
B:HIS170
|
2.2
|
31.5
|
1.0
|
CL
|
B:CL1300
|
2.3
|
30.8
|
1.0
|
CD2
|
B:HIS170
|
3.5
|
20.3
|
1.0
|
ND1
|
B:HIS170
|
3.5
|
32.4
|
1.0
|
HB2
|
B:ALA135
|
3.6
|
19.5
|
1.0
|
HB3
|
B:ALA135
|
3.8
|
19.5
|
1.0
|
HD2
|
B:HIS170
|
4.1
|
24.4
|
1.0
|
CG
|
B:HIS170
|
4.2
|
22.5
|
1.0
|
CB
|
B:ALA135
|
4.2
|
16.3
|
1.0
|
O
|
B:HOH2152
|
4.5
|
22.2
|
1.0
|
HA
|
B:ALA135
|
4.6
|
19.7
|
1.0
|
HG22
|
B:THR169
|
4.8
|
33.0
|
1.0
|
O
|
B:HOH2066
|
4.8
|
20.5
|
1.0
|
HB1
|
B:ALA135
|
4.9
|
19.5
|
1.0
|
HH
|
B:TYR137
|
5.0
|
31.0
|
1.0
|
CA
|
B:ALA135
|
5.0
|
16.4
|
1.0
|
|
Reference:
T.Christopeit,
T.J.O.Carlsen,
R.Helland,
H.K.S.Leiros.
Discovery of Novel Inhibitor Scaffolds Against the Metallo-Beta-Lactamase Vim-2 By Spr Based Fragment Screening J.Med.Chem. V. 58 8671 2015.
ISSN: ISSN 0022-2623
PubMed: 26477515
DOI: 10.1021/ACS.JMEDCHEM.5B01289
Page generated: Sun Oct 27 12:50:27 2024
|